Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Clin Infect Dis
1 J Infect
2 J Infect Dis
1 MMWR Morb Mortal Wkly Rep
1 N Engl J Med
1 Nat Med
2 Pediatrics
1 PLoS Med
2 PLoS One
23 Vaccine

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles


    Covid-19 vaccination in the UK: the Joint Committee on Vaccination and Immunisation's infrastructure.
    BMJ. 2022;379:o2685.

    Clin Infect Dis

  2. OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
    Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
    Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
    PubMed         Abstract available

    J Infect

  3. MASHIMO Y, Yamazaki K, Kageyama T, Tanaka S, et al
    Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine.
    J Infect. 2022 Nov 2. pii: S0163-4453(22)00614.

    J Infect Dis

  4. EIDEN J, Fierro C, Schwartz H, Adams M, et al
    Intranasal M2SR (M2-deficient Single Replication) H3N2 Influenza Vaccine Provides Enhanced Mucosal and Serum Antibodies In Adults.
    J Infect Dis. 2022 Nov 9. pii: 6807529. doi: 10.1093.
    PubMed         Abstract available

  5. STIEH DJ, Barouch DH, Comeaux C, Sarnecki M, et al
    Safety and Immunogenicity of Ad26-vectored HIV Vaccine with Mosaic Immunogens and a Novel Mosaic Envelope Protein in HIV-uninfected Adults: A Phase 1/2a Study.
    J Infect Dis. 2022 Nov 9. pii: 6812747. doi: 10.1093.
    PubMed         Abstract available


    Shifting Hepatitis A Epidemiology Requires Renewed Vaccination Efforts.
    JAMA. 2022;328:1800.

    Single Monkeypox Vaccine Dose Provides Some Protection.
    JAMA. 2022;328:1801.

    MMWR Morb Mortal Wkly Rep

  8. RYERSON AB, Lang D, Alazawi MA, Neyra M, et al
    Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case - New York, March 9-October 11, 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:1418-1424.
    PubMed         Abstract available

    N Engl J Med

  9. CANETTI M, Barda N, Gilboa M, Indenbaum V, et al
    Six-Month Follow-up after a Fourth BNT162b2 Vaccine Dose.
    N Engl J Med. 2022 Nov 9. doi: 10.1056/NEJMc2211283.

    Nat Med

  10. Quantifying the effect of inequitable global vaccine coverage on the COVID-19 pandemic.
    Nat Med. 2022 Nov 4. pii: 10.1038/s41591-022-02065.


  11. KAMIDANI S, Panagiotakopoulos L, Licata C, Daley MF, et al
    Kawasaki Disease Following the 13-valent Pneumococcal Conjugate Vaccine and Rotavirus Vaccines.
    Pediatrics. 2022 Nov 9. pii: 189926. doi: 10.1542/peds.2022-058789.
    PubMed         Abstract available

  12. EDWARDS JG, Cheston CC, Kelly CA, Brewster RCL, et al
    A Community-Based COVID-19 Vaccine Education Initiative.
    Pediatrics. 2022 Nov 9. pii: 189927. doi: 10.1542/peds.2022-057374.
    PubMed         Abstract available

    PLoS Med

  13. BABOUEE FLURY B, Gusewell S, Egger T, Leal O, et al
    Risk and symptoms of COVID-19 in health professionals according to baseline immune status and booster vaccination during the Delta and Omicron waves in Switzerland-A multicentre cohort study.
    PLoS Med. 2022;19:e1004125.
    PubMed         Abstract available

    PLoS One

  14. OTHMAN B, Barakat M, Omar A, Al-Rawashdeh A, et al
    Evaluation of hepatitis B knowledge, practices, and beliefs among the Jordanian population: A cross-sectional study.
    PLoS One. 2022;17:e0277186.
    PubMed         Abstract available

  15. SAKAMOTO M, Ishizuka R, Ozawa C, Fukuda Y, et al
    Health information and COVID-19 vaccination: Beliefs and attitudes among Japanese university students.
    PLoS One. 2022;17:e0277435.
    PubMed         Abstract available


  16. GHIANI M, Hagemann C, Friedrich J, Maywald U, et al
    Can risk area designation help increase vaccination coverage for Tick-Borne Encephalitis? Evidence from German claims data.
    Vaccine. 2022 Nov 5. pii: S0264-410X(22)01346.
    PubMed         Abstract available

  17. LEUNG J, Gray EB, Anderson TC, Sharkey SM, et al
    Recombinant zoster vaccine (RZV) second-dose series completion in adults aged 50-64 years in the United States.
    Vaccine. 2022 Nov 5. pii: S0264-410X(22)01328.
    PubMed         Abstract available

  18. THOMMES E, Coudeville L, Muhammad R, Martin M, et al
    Public health impact and cost-effectiveness of implementing a 'pre-vaccination screening' strategy with the dengue vaccine in Puerto Rico.
    Vaccine. 2022 Nov 5. pii: S0264-410X(22)01343.
    PubMed         Abstract available

  19. LIU S, Yang G, Li M, Sun F, et al
    Transcutaneous immunization via dissolving microneedles protects mice from lethal influenza H7N9 virus challenge.
    Vaccine. 2022 Oct 12. pii: S0264-410X(22)01102.
    PubMed         Abstract available

  20. MARTINI M, Orsini D
    The fight against poliomyelitis through the history: past, present and hopes for the future. Albert Sabin's missing Nobel and his "gift to all the world's children".
    Vaccine. 2022;40:6802-6805.
    PubMed         Abstract available

  21. ECHEVERRIA-LONDONO S, Hartner AM, Li X, Roth J, et al
    Exploring the subnational inequality and heterogeneity of the impact of routine measles immunisation in Africa.
    Vaccine. 2022;40:6806-6817.
    PubMed         Abstract available

  22. REN H, Li H, Cao L, Wang Z, et al
    Intranasal immunization with HRSV prefusion F protein and CpG adjuvant elicits robust protective effects in mice.
    Vaccine. 2022;40:6830-6838.
    PubMed         Abstract available

  23. YU X, Suo L, Li W, Chen W, et al
    Molecular surveillance of rubella virus in Beijing, China during 2010-2021: Progress and challenges in rubella elimination.
    Vaccine. 2022;40:6857-6863.
    PubMed         Abstract available

  24. MORRILL JC, Peters CJ, Bettinger GE, Palermo PM, et al
    Rift Valley fever MP-12 vaccine elicits an early protective immune response in mice.
    Vaccine. 2022 Nov 1. pii: S0264-410X(22)01339.
    PubMed         Abstract available

  25. MARIE REINHART A, Tian Y, Lilly AE
    The role of trust in COVID-19 vaccine hesitancy and acceptance among Black and White Americans.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01330.
    PubMed         Abstract available

  26. CAREY KA, Newman LM, Spicknall IH
    Estimating the population level impact of a gonococcal vaccine candidate: Predictions from a simple mathematical model.
    Vaccine. 2022 Nov 1. pii: S0264-410X(22)01291.
    PubMed         Abstract available

  27. FISHER DG, Gnazzo V, Holthausen DJ, Lopez CB, et al
    Non-standard viral genome-derived RNA activates TLR3 and type I IFN signaling to induce cDC1-dependent CD8+ T-cell responses during vaccination in mice.
    Vaccine. 2022 Nov 1. pii: S0264-410X(22)01312.
    PubMed         Abstract available

  28. SIANI A, Tranter A
    Is vaccine confidence an unexpected victim of the COVID-19 pandemic?
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01337.
    PubMed         Abstract available

  29. CAPURRO G, Maier R, Tustin J, Jardine CG, et al
    "They're trying to bribe you and taking away your freedoms": COVID-19 vaccine hesitancy in communities with traditionally low vaccination rates.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01338.
    PubMed         Abstract available

  30. HAYMAN B, Kumar Suri R, Downham M
    Sustainable vaccine manufacturing in low- and middle-Income countries.
    Vaccine. 2022 Nov 2. pii: S0264-410X(22)01305.
    PubMed         Abstract available

  31. WATESKA AR, Patricia Nowalk M, Lin CJ, Harrison LH, et al
    Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old.
    Vaccine. 2022 Nov 3. pii: S0264-410X(22)01340.
    PubMed         Abstract available

  32. HALL PA, Meng G, Sakib MN, Quah ACK, et al
    Do the vaccinated perform less distancing, mask wearing and hand hygiene? A test of the risk compensation hypothesis in a representative sample during the COVID-19 pandemic.
    Vaccine. 2022 Oct 20. pii: S0264-410X(22)01289.
    PubMed         Abstract available

  33. RICKS T, Trent MJ, MacIntyre CR
    Predictors of herpes zoster vaccination among Australian adults aged 65 and over.
    Vaccine. 2022 Nov 3. pii: S0264-410X(22)01332.
    PubMed         Abstract available

  34. LIMAYE RJ, Paul A, Gur-Arie R, Zavala E, et al
    A socio-ecological exploration to identify factors influencing the COVID-19 vaccine decision-making process among pregnant and lactating women: Findings from Kenya.
    Vaccine. 2022 Oct 31. pii: S0264-410X(22)01331.
    PubMed         Abstract available

  35. MALTEZOU HC, Ledda C, Gagneux-Brunon A, Botelho-Nevers E, et al
    Mandatory COVID-19 vaccination for healthcare personnel in the era of new SARS-CoV-2 variants.
    Vaccine. 2022 Oct 26. pii: S0264-410X(22)01313.

  36. PRIYAMVADA L, Carson WC, Ortega E, Navarra T, et al
    Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Vaccine. 2022 Nov 4. pii: S0264-410X(22)01360.
    PubMed         Abstract available

  37. SCHIFF J, Schmidt AR, Pham PK, Perez JB, et al
    Parental attitudes in the pediatric emergency department about the COVID-19 vaccine.
    Vaccine. 2022 Oct 26. pii: S0264-410X(22)01309.
    PubMed         Abstract available

  38. KRASSELT J, Robin D, Fadda M, Geutjes A, et al
    Tick-Talk: Parental online discourse about TBE vaccination.
    Vaccine. 2022 Nov 5. pii: S0264-410X(22)01326.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.